The future of cancer costs will likely be shaped by advancements in technology, changes in healthcare policy, and efforts to improve efficiency within healthcare systems. Emphasis on preventive measures and early detection can potentially reduce costs by decreasing the need for extensive treatment. Collaboration between governments, healthcare providers, and the pharmaceutical industry will be crucial in addressing the complex issue of cancer costs and ensuring sustainable, equitable access to care for all patients.
